[Press] CES 2024: Elevance Health launches program to provide digital health-enabled smartphones to Medicaid members

CES 2024: Elevance Health launches program to provide digital health-enabled smartphones to Medicaid members (https://www.fiercehealthcare.com/payers/ces-2024-elevance-health-launches-program-provide-digital-health-enabled-smartphones)By Paige MinemyerJan 10, 2024 4:13pm In the wake of the COVID-19 pandemic, virtual care and digital health tools are more popular than ever. However, a significant digital divide persists, making it far difficult for some patient populations to access theseContinue reading “[Press] CES 2024: Elevance Health launches program to provide digital health-enabled smartphones to Medicaid members”

[Press] CES 2024: Mark Cuban, Glen Tullman sound off on building new models of care for consumers and AI’s impact

CES 2024: Mark Cuban, Glen Tullman sound off on building new models of care for consumers and AI’s impactBy Heather LandiJan 11, 2024 7:00pm(https://www.fiercehealthcare.com/ai-and-machine-learning/ces-2024-mark-cuban-says-increased-adoption-ai-could-lead-less-access) LAS VEGAS — Artificial intelligence was dominating CES 2024 this week. From assistive speech tools to pet wearables to AI-enabled pillows to prevent snoring, the majority of companies exhibiting at CESContinue reading “[Press] CES 2024: Mark Cuban, Glen Tullman sound off on building new models of care for consumers and AI’s impact”

About Hepatocellular Carcinoma, in terms of treatments and its clinical trials

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and ranks among the top causes of cancer-related deaths. The current treatment options for HCC include the following: In the early stages of HCC, complete surgical resection is often possible. Liver transplantation is a suitable treatment for patients with liver function impairment, as itContinue reading “About Hepatocellular Carcinoma, in terms of treatments and its clinical trials”

Why do we use Kernel-smoothed hazard function in clinical trials?

The Kernel-smoothed hazard function is a statistical method used to estimate the hazard function continuously over time. This approach is particularly useful in survival analysis, where the interest is in understanding the event rate (such as death or failure) at any given point in time. Here are a few reasons why researchers might choose toContinue reading “Why do we use Kernel-smoothed hazard function in clinical trials?”